Jerusalem, Israel

Ron Dzikowski

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Technische Universitat Braunschweig, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2019.


 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ron Dzikowski

Introduction

Ron Dzikowski is a notable inventor based in Jerusalem, IL. He has made significant contributions to the field of chemistry, particularly in the development of compounds with antiprotozoal activity. His work has implications for the treatment of diseases caused by parasites, including malaria.

Latest Patents

Dzikowski holds a patent for "Indole compounds having antiprotozoal activity and its use as well as methods for producing the same." This invention relates to new bisindolylcyclobuten-dione-based structures that exhibit antiprotozoal properties. The patent outlines pharmaceutical compositions that utilize these compounds for the prophylaxis and treatment of parasite-based diseases, specifically malaria. Additionally, it provides methods for treating such diseases.

Career Highlights

Throughout his career, Ron Dzikowski has worked with esteemed institutions, including Technische Universität Braunschweig and Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His experience in these organizations has contributed to his expertise in the field of pharmaceutical chemistry.

Collaborations

Dzikowski has collaborated with notable colleagues, including Conrad Kunick and Hoang Lande. These partnerships have likely enriched his research and development efforts.

Conclusion

Ron Dzikowski's innovative work in developing antiprotozoal compounds showcases his commitment to addressing significant health challenges. His contributions are vital in the ongoing fight against diseases like malaria.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…